These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 40511)

  • 1. [The "the therapeutic window" of neuroleptic levels in the erythrocytes of schizophrenics (proceedings)].
    Yesavage JA
    Ann Med Psychol (Paris); 1979; 137(3-4):251. PubMed ID: 40511
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapse rate and low serum neuroleptic levels in schizophrenics treated with fluphenazine: another view.
    Boza RA; Milanes F; Starkey T; Slater V; Dominguez F
    J Clin Psychiatry; 1988 Jun; 49(6):245. PubMed ID: 2897960
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic-refractory patients and their drug plasma levels.
    Berrios GE
    Encephale; 1982; 8(4):465-85. PubMed ID: 6129961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings.
    Greenberg JS; Brown WA; Laughren TP; Krantz J
    Psychopharmacol Bull; 1983; 19(1):74-6. PubMed ID: 6131470
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic concentrations in schizophrenic patients: measurements by radioreceptor assay and gas chromatography.
    Javaid JI; Davis JM; Dysken MW; Janicak P; Casper R
    Psychopharmacol Bull; 1983; 19(1):72-4. PubMed ID: 6131469
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between plasma and red blood cell neuroleptic levels, oral dosage, and clinical parameters in a chronic schizophrenic population.
    Dunlop SR; Shea PA; Hendrie HC
    Biol Psychiatry; 1982 Aug; 17(8):929-36. PubMed ID: 6126231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of treatment response in schizophrenia: clinical use of neuroleptic blood levels.
    Tang SW
    Can J Psychiatry; 1985 Jun; 30(4):249-50. PubMed ID: 2861888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic blood levels in outpatient maintenance therapy of schizophrenia.
    Sajadi C; Smith RC; Shvartsburd A; Morton V; Mirabi M; Gordon J
    Psychopharmacol Bull; 1984; 20(1):110-3. PubMed ID: 6144129
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum neuroleptic levels in the maintenance treatment of schizophrenia.
    Brown WA; Laughren T
    Psychopharmacol Bull; 1983; 19(1):76-8. PubMed ID: 6131471
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of relationship of neuroleptic dose and blood serum levels to neuropsychological performance on the LNNB in chronic schizophrenia.
    Puente AE; Tune L
    Int J Neurosci; 1996 Oct; 87(1-2):107-10. PubMed ID: 8913825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin uptake and efflux in blood platelets from untreated and neuroleptic-treated schizophrenics.
    Lingjaerde O
    Biol Psychiatry; 1983 Dec; 18(12):1345-56. PubMed ID: 6140960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.
    Akiyama K; Tsuchida K; Kanzaki A; Ujike H; Hamamura T; Kondo K; Mutoh S; Miyanagi K; Kuroda S; Otsuki S
    Biol Psychiatry; 1995 Nov; 38(10):639-48. PubMed ID: 8555375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamics of the serum pipothiazine level in patients with schizophrenia during long-term treatment with this neuroleptic agent].
    Lipska B; Szukalski B; Nurowska K; Welbel L
    Psychiatr Pol; 1987; 21(1):14-9. PubMed ID: 2887001
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum prolactin levels in chronic schizophrenics].
    Ravalli S; Barone R; Molinaro G; Leone NB
    Minerva Psichiatr; 1987; 28(1):31-4. PubMed ID: 2888003
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP; Smith D; Katz I
    J Clin Psychiatry; 1984 Mar; 45(3):117-9. PubMed ID: 6142035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of risperidone concentration under chlorprothixene comedication--a case report.
    Bader W; Greiner C; Haen E
    Pharmacopsychiatry; 2008 May; 41(3):116-7. PubMed ID: 18484554
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment.
    Hernandez I; Sokolov BP
    J Neurosci Res; 2000 Jan; 59(2):218-25. PubMed ID: 10650880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin and neuroleptic drugs.
    Green AI; Brown WA
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):213-23. PubMed ID: 2897910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood levels of beta-endorphins and the changes caused by neuroleptics in acute and chronic schizophrenics].
    Barcia D; Martínez A; López L; Ruiz ME; Galiana M; Muñoz R; Huertas F
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):3-10. PubMed ID: 6144248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.